James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website
James “Jim” Sigg FDA\'s Deputy Commissioner for Operations and Chief Operating Officer | Official Website
This is a 66.7% increase over the number of companies inspected in the previous quarter, when three companies received three inspections.
Most of the companies inspected at the time were involved in the Biologics sector. The second most common type of company inspected worked in the Devices sector.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
ARK-LA-TEX Fertility and Reproductive Medicine, PMC | Biologics | 08/23/2023 | No Action Indicated (NAI) |
E & A Labs and Imaging, LLC | Biologics | 08/24/2023 | No Action Indicated (NAI) |
Holly C. Wall, M.D. | Devices | 08/03/2023 | No Action Indicated (NAI) |
LifeShare Blood Center | Biologics | 08/31/2023 | No Action Indicated (NAI) |
Simeon H. Wall, Jr, M.D. | Devices | 08/03/2023 | No Action Indicated (NAI) |